Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 1.54 B—825 M1.77 B1.41 B1.44 B 5.45 B Research & development —————— — Operating income 00244 M-339 M616 M475 M 996 M Non-Operating Income, Total 0016 M-31 M14 M-19 M -20 M Interest expense, net of interest capitalized 217 M—138 M228 M238 M255 M 859 M Non-Operating Income, excl. Interest Expenses 00-114 M-228 M-200 M-240 M -782 M Unusual income/expense 00-8 M-31 M-24 M-34 M -97 M Pretax income 0089 M-669 M330 M161 M -89 M Equity in earnings 73 M—-33 M-71 M-62 M-54 M -220 M Taxes 0085 M-125 M155 M120 M 235 M Non-controlling/minority interest 9 M—17 M29 M7 M0 53 M After tax other income/expense —————— — Net income before discontinued operations 00-13 M-573 M168 M41 M -377 M Discontinued operations ——00—— — Net income 00-13 M-573 M168 M41 M -377 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 00-13 M-573 M168 M41 M -377 M Basic earnings per share (Basic EPS) 00-0.01-0.520.150.04 -0.34 Diluted earnings per share (Diluted EPS) 00-0.01-0.520.150.04 -0.34 Average basic shares outstanding 1 0001 0001.1 B1.1 B1.11 B1.12 B — Diluted shares outstanding 1 0001 0001.1 B1.1 B1.12 B1.12 B — EBITDA ———154 M—— — EBIT ——244 M-339 M616 M475 M 996 M Cost of revenue 4.96 B—2.64 B5.77 B4.86 B4.44 B 17.71 B Other cost of goods sold 4.96 B—2.64 B5.77 B4.86 B4.44 B 17.71 B Depreciation & amortization (cash flow) ———493 M—— —